Phase III post-marketing commitment study data paves way for usage of Paratek’s Nuzyra in other indications: GlobalData Read more
Eisai and Biogen’s Leqembi launch in China marks turning point in Alzheimer’s treatment, says GlobalData Read more
Oral JAK inhibitor LEQSELVI (deuruxolitinib) approved by US FDA for severe alopecia areata treatment Read more